Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
Zehua Ma(Shanghai Jiao Tong University), Wei Xue(National Sun Yat-sen University), Yiyi Ji(Shanghai Jiao Tong University), Qi Wang(Tongji University), Kai Shen(Renji Hospital), Weiwei Zhang(Shanghai Jiao Tong University), Zhixiang Xin(Shanghai Cancer Institute), Baijun Dong(Renji Hospital), Ruopeng Su(Renji Hospital), Jiahua Pan(University of Science and Technology of China)
Cited by 119
Related Papers
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
The Biogenesis of Nascent Circular RNAs
|Cell Reports|2016|694
Genome sequence and genetic diversity of the common carp, Cyprinus carpio
|Nature Genetics|2014|677
Coordinated circRNA Biogenesis and Function with NF90/NF110 in Viral Infection
|Molecular Cell|2017|666